Affimed NV (NASDAQ:AFMD)
| 2.15 Delayed Data As of Oct 04 |  +0.01 / +0.47%Today’s Change | 1.93 Today|||52-Week Range 7.35 | -61.05% Year-to-Date |
Latest AFMD News | Press Releases
No recent news for Affimed NV.
Today’s Trading
| Previous close | 2.14 |
| Today’s open | 2.19 |
| Day’s range | 2.12 - 2.24 |
| Volume | 34,090 |
| Average volume (3 months) | 1,069,068 |
| Market cap | $300.6M |
Data as of 4:00pm ET, 10/04/2022
Growth & Valuation
| Earnings growth (last year) | -0.71% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +47.58% |
| P/E ratio | NM |
| Price/Sales | 13.83 |
| Price/Book | 1.64 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| OCULOcular Therapeutix I... | +0.33 | +8.08% |
| CNCEConcert Pharmaceutic... | +0.11 | +1.67% |
| STROSutro Biopharma Inc | +0.09 | +1.55% |
| AVDLAvadel Pharmaceutica... | +0.88 | +17.53% |
Data as of 4:00pm ET, 10/04/2022
Financials
| Next reporting date | November 9, 2022 |
| EPS forecast (this quarter) | -$0.16 |
| Annual revenue (last year) | $47.7M |
| Annual profit (last year) | -$68.0M |
| Net profit margin | -142.50% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Heidelberg, Baden Wuerttemberg |
Forecasts
